Interim guidance for rapid antigen testing for SARS-CoV-2
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All


Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to:

Interim guidance for rapid antigen testing for SARS-CoV-2

  • Published Date:

    Aug. 29, 2020

  • Language:
Filetype[PDF-229.59 KB]

  • Description:
    Updated Aug. 29, 2020 Note: Antigen tests can be used in a variety of testing strategies to respond to the coronavirus disease 2019 (COVID-19) pandemic. This interim guidance is intended for clinicians who order antigen tests, receive antigen test results, and/or perform point of care testing, as well as for laboratory professionals who perform antigen testing in a laboratory setting or at the point of care and report those results. The purpose of this interim technical guidance is to support the most effective use of antigen tests for different testing situations. This guidance applies to all uses of antigen tests and is not specific to the application of antigen tests to any particular age group or setting. This guidance supplements and is consistent with CDC’s Overview of Testing for SARS-CoV-2 guidance. CDC has also provided a summary of considerations for using antigen tests in nursing home facilities.
  • Content Notes:
    Definitions of Diagnostic, Screening, and Surveillance Testing for SARS-CoV-2 -- Rapid Antigen Testing for SARS-CoV-2 -- Summary Tables.
  • Document Type:
  • Place as Subject:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: